Trial Title:
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
NCT ID:
NCT06079671
Condition:
Locally Advanced Cervical Cancer
Conditions: Official terms:
Uterine Cervical Neoplasms
Conditions: Keywords:
Locally Advanced Cervical Cancer;
Adolescent and Young Adult;
Volrustomig
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking description:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Intervention:
Intervention type:
Biological
Intervention name:
Volrustomig
Description:
IV Infusion
Arm group label:
Volrustomig
Intervention type:
Other
Intervention name:
Placebo
Description:
IV Infusion
Arm group label:
Placebo
Other name:
Saline
Summary:
This is a phase III, randomized, double-blind, placebo-controlled, multi-center, global
study to explore the efficacy and safety of volrustomig in women with high-risk LACC
(FIGO 2018 stage IIIC to IVA cervical cancer with lymph node involvement) who have not
progressed following platinum-based CCRT.
Detailed description:
Women with locally advanced cervical cancer will be randomized in a 1:1 ratio to receive
treatment with Volrustomig or Placebo.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
For inclusion in the study, patients should fulfill the following criteria:
1. Female.
2. Aged at least 15 years at the time of screening.
3. Body weight > 35 kg.
4. Histologically documented FIGO 2018 Stage IIIC to IVA cervical adenocarcinoma,
cervical squamous carcinoma, or cervical adenosquamous carcinoma, with lymph node
involvement.
5. Initial staging procedures performed no more than 42 days prior to the first dose of
CCRT.
6. Provision of tumor sample to assess the PD-L1 expression.
7. Must not have progressed following CCRT, participants with persistent disease after
definitive CCRT must not be amenable to other available therapies with curative
intent.
8. WHO/ECOG performance status of 0 or 1.
9. Adequate organ and bone marrow function.
10. Capable of providing signed informed consent.
Exclusion Criteria:
Patients should not enter the study if any of the following exclusion criteria are
fulfilled:
1. Diagnosis of small cell (neuroendocrine) or mucinous adenocarcinoma of cervical
cancer.
2. Evidence of metastatic disease.
3. Intent to administer a fertility-sparing treatment regimen.
4. History of organ transplant.
5. Active or prior documented autoimmune or inflammatory disorders.
6. Uncontrolled intercurrent illness.
7. History of another primary malignancy except for a) Malignancy treated with curative
intent with no known active disease ≥2 years before the first dose of study
intervention; b) Adequately treated nonmelanoma skin cancer or lentigo maligna, or
carcinoma in situ without evidence of disease.
8. Unresolved toxicities from previous CCRT except for irreversible toxicity that is
not reasonably expected to be exacerbated.
9. Prior history or presence of vesicovaginal, colovaginal, or rectovaginal fistula.
10. History of anaphylaxis to any biologic therapy or vaccine.
11. Current or prior use of immunosuppressive medication within 14 days before the first
dose of the study intervention is excluded. The following are exceptions to this
criterion: a) Intranasal, inhaled, topical steroids, or local steroid injections
(eg, intraarticular injection); b) Steroids as premedication for hypersensitivity
reactions (eg, CT scan premedication or chemotherapy premedication) or a single dose
for palliative purpose (eg, pain control).
12. Patients who have undergone a previous hysterectomy, including a supracervical
hysterectomy, or will have a hysterectomy as part of their initial cervical cancer
therapy.
13. Any prior (besides prior CCRT) or concurrent treatment for cervical cancer.
14. Major surgical procedures within 4 weeks prior to the first dose of the study
intervention or still recovering from prior surgery.
15. Exposure to immune mediated therapy prior to the study for any indication.
16. Receipt of live attenuated vaccine within 30 days prior to the first dose of the
study intervention.
17. Participants with a known allergy or hypersensitivity to the study intervention, or
any excipients of the study intervention.
Gender:
Female
Gender based:
Yes
Minimum age:
15 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Research Site
Address:
City:
Birmingham
Zip:
35233
Country:
United States
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Phoenix
Zip:
85016
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Tucson
Zip:
85711
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Little Rock
Zip:
72205
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
La Jolla
Zip:
92093
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
West Hollywood
Zip:
90048
Country:
United States
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Atlanta
Zip:
30322
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Augusta
Zip:
30912
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Savannah
Zip:
31405
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Melrose Park
Zip:
60160
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Indianapolis
Zip:
46202
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
New Orleans
Zip:
70112
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
New Orleans
Zip:
70121
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Shreveport
Zip:
71103
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
New York
Zip:
10016
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Syracuse
Zip:
13210
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Cleveland
Zip:
44195
Country:
United States
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Columbus
Zip:
43210
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Eugene
Zip:
97401
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Philadelphia
Zip:
19107
Country:
United States
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Providence
Zip:
02905
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Dallas
Zip:
75390
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Fort Worth
Zip:
76104
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Houston
Zip:
77030
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Tyler
Zip:
75702
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Charlottesville
Zip:
22908
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Richmond
Zip:
23298
Country:
United States
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Barretos
Zip:
14784-400
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Belo Horizonte
Zip:
30130-100
Country:
Brazil
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Curitiba
Zip:
80730-150
Country:
Brazil
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Fortaleza
Zip:
60336-045
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Porto Alegre
Zip:
90110-270
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Porto Alegre
Zip:
90619-900
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Porto Velho
Zip:
76834-899
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Rio de Janeiro
Zip:
20231-050
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Salvador
Zip:
40050 410
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Sao Paulo
Zip:
1323001
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
São Paulo
Zip:
01246-000
Country:
Brazil
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Teresina
Zip:
64049-200
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Hamilton
Zip:
L8V 1C3
Country:
Canada
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
London
Zip:
N6A 5W9
Country:
Canada
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Toronto
Zip:
M4N 3M5
Country:
Canada
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Toronto
Zip:
M5G 2M9
Country:
Canada
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Montreal
Zip:
H2X 0C1
Country:
Canada
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Montreal
Zip:
H3G 1A4
Country:
Canada
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Ste-Foy
Zip:
G1V 4G2
Country:
Canada
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Beijing
Zip:
100730
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Changde
Zip:
415003
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Changsha
Zip:
410008
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Changsha
Zip:
410013
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Chengdu
Zip:
610041
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Chongqing
Zip:
400030
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Fuzhou
Zip:
350014
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Guangzhou
Zip:
510060
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Guangzhou
Zip:
510120
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Hangzhou
Zip:
310022
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Harbin
Zip:
150081
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Kunming
Zip:
650118
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Lanzhou
Zip:
730000
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Lanzhou
Zip:
730050
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Luzhou
Zip:
646000
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Nanchang
Zip:
330006
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Nanchang
Zip:
330029
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Shandong
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Shanghai
Zip:
200032
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Shanghai
Zip:
200080
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Shenyang
Zip:
110004
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
TianJin
Zip:
300060
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Wuhan
Zip:
430022
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Wuhan
Zip:
430030
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Xi'an
Zip:
710061
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Yinchuan
Zip:
750004
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Zhengzhou
Zip:
450008
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Zhengzhou
Zip:
450052
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Aarhus N
Zip:
8200
Country:
Denmark
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
København Ø
Zip:
2100
Country:
Denmark
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Odense
Zip:
5000
Country:
Denmark
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Calicut
Zip:
673601
Country:
India
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Jaipur
Zip:
302017
Country:
India
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Lucknow
Zip:
226003
Country:
India
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Madurai
Zip:
625107
Country:
India
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Mohali
Zip:
160055
Country:
India
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Nagpur
Zip:
440001
Country:
India
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Nashik
Zip:
422009
Country:
India
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Nashik
Zip:
422011
Country:
India
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
New Delhi
Zip:
11029
Country:
India
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Vadodara
Zip:
391760
Country:
India
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Bari
Zip:
70124
Country:
Italy
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Bologna
Zip:
40138
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Catania
Zip:
95126
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Firenze
Zip:
50141
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Lecco
Zip:
23900
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Milano
Zip:
20133
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Milan
Zip:
20141
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Monza
Zip:
20900
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Napoli
Zip:
80131
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Roma
Zip:
161
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Rome
Zip:
00168
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Rozzano
Zip:
20089
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Turin
Zip:
10128
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Fukuoka-shi
Zip:
812-8582
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Hidaka-shi
Zip:
350-1298
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Kagoshima-shi
Zip:
890-8520
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Koto-ku
Zip:
135-8550
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Kurume-shi
Zip:
830-0011
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Maebashi-shi
Zip:
371-8511
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Matsuyama-shi
Zip:
791-0280
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Morioka-shi
Zip:
028-3695
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Nagoya-shi
Zip:
464-8681
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Nakagami-gun
Zip:
903-0215
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Osaka-shi
Zip:
541-8567
Country:
Japan
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Sapporo-shi
Zip:
003-0804
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Sapporo-shi
Zip:
060-8638
Country:
Japan
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Shinjuku-ku
Zip:
160-8582
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Suita-shi
Zip:
565-0871
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Sunto-gun
Zip:
411-8777
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Toon-Shi
Zip:
791-0295
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Seoul
Zip:
03080
Country:
Korea, Republic of
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Seoul
Zip:
03722
Country:
Korea, Republic of
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Seoul
Zip:
06351
Country:
Korea, Republic of
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Seoul
Zip:
5505
Country:
Korea, Republic of
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Ciudad de México
Zip:
03240
Country:
Mexico
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Coyoacan
Zip:
04380
Country:
Mexico
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Culiacan
Zip:
80040
Country:
Mexico
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Guadalajara
Zip:
44650
Country:
Mexico
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Guadalajra
Zip:
44260
Country:
Mexico
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Mexico
Zip:
14080
Country:
Mexico
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Monterrey
Zip:
64460
Country:
Mexico
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
México
Zip:
04700
Country:
Mexico
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Oslo
Zip:
424
Country:
Norway
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Trondheim
Zip:
7030
Country:
Norway
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Concepción
Zip:
12125
Country:
Peru
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Lima
Zip:
15036
Country:
Peru
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Lima
Zip:
15038
Country:
Peru
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Lima
Zip:
15102
Country:
Peru
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Lima
Zip:
LIMA 29
Country:
Peru
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Białystok
Zip:
15-027
Country:
Poland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Gdańsk
Zip:
80-214
Country:
Poland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Gliwice
Zip:
44-101
Country:
Poland
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Kraków
Zip:
30-348
Country:
Poland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Poznan
Zip:
61-866
Country:
Poland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Warszawa
Zip:
02-781
Country:
Poland
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Wroclaw
Zip:
53-413
Country:
Poland
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Łódź
Zip:
90-513
Country:
Poland
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
San Juan
Zip:
00927
Country:
Puerto Rico
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Barcelona
Zip:
08036
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Barcelona
Zip:
8035
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Cordoba
Zip:
14004
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Girona
Zip:
17007
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Hospitalet deLlobregat
Zip:
08907
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
La Coruna
Zip:
15006
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Madrid
Zip:
28034
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Madrid
Zip:
28040
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Madrid
Zip:
28041
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Madrid
Zip:
28046
Country:
Spain
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Palma de Mallorca
Zip:
07010
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Valencia
Zip:
46009
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Valencia
Zip:
46010
Country:
Spain
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Kaohsiung city
Zip:
833
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Kaohsiung
Zip:
81362
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
New Taipei
Zip:
220
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Taichung
Zip:
40705
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Tainan
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Taipei
Zip:
10449
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Taipei
Zip:
11217
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Taoyuan
Zip:
333
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Ankara
Zip:
06100
Country:
Turkey
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Ankara
Zip:
06490
Country:
Turkey
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Istanbul
Zip:
32098
Country:
Turkey
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Istanbul
Zip:
34214
Country:
Turkey
Status:
Withdrawn
Start date:
September 22, 2023
Completion date:
October 24, 2029
Lead sponsor:
Agency:
AstraZeneca
Agency class:
Industry
Collaborator:
Agency:
Gynecologic Oncology Group Foundation
Agency class:
Other
Collaborator:
Agency:
European Network for Gynaecological Oncological Trial Groups
Agency class:
Other
Source:
AstraZeneca
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06079671
